Byetta is a prescription drug that helps manage blood sugar in adults with type 2 diabetes. Learn about its mild to serious side effects and how to manage them.

Incretin-based treatments may improve beta cell function, and, while not indicated for these effects, GLP-1 receptor agonists may also promote satiety, reduce weight, slow gastric emptying, and ...

Biotech. Cell & Gene Therapy; Clinical Data; Venture Capital; Devices; Diagnostics; AI and Machine Learning; CRO; Special Reports ...

BYETTA exhibits many of the same effects as the human incretin hormone GLP-1. GLP-1 improves blood sugar after food intake through multiple effects that work in concert on the stomach, liver ...

The usual Byetta dosage for high blood sugar is 5 to 10 micrograms (mcg) twice per day. Specific dosages may vary depending on any side effects you experience or other conditions you may have. The ...

Incretin therapies: ... (Byetta, Amylin) therapy for ... They have a lesser effect on fasting glucose and on HbA1c reductions than do conventional first-line agents such as metformin, ...

Glucagon-like peptide-1 (GLP-1) receptor agonists -- your patients are on them, and perhaps you are too (or at least have thought about it). In 2023, more than 500 million people worldwide were ...

Awards. CRO Awards; Innovation Awards; Resources. Podcasts; Fierce Events; Industry Events; Webinars; Whitepapers ...

Incretin drugs are a relatively new family of drugs for people with Type 2 diabetes. They work by elevating the level of GLP-1, an incretin hormone found in the gut, which has the effect of ...

Incretin-based therapies have advanced treatment of type 2 diabetes but have been linked to pancreatitis and pancreatic cancer in some patients.